H-11892: A Current Practice Study Of Rituxan In Patients Receiving BEAM Chemotherapy And Autologous Blood Stem Cell Transplantation For High Risk Lymphoma And Hodgkin's Disease:This study uses a monoclonal antibody and high dose chemotherapy combined with autologous stem cell transplantation.